Antibiotic treatment for community acquired pneumonia in children till five years of age at a private hospital in Ekurhuleni
Date
2021
Authors
Munda, Kudzaishe
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Pneumonia is the leading cause of death in children below the age of five years. There
are two categories of pneumonia which are community acquired pneumonia (CAP) and
hospital acquired pneumonia (HAP). Pneumonia can be prevented through vaccination.
However, the prevalence of other causes of pneumonia other than bacterial causes for
example, viral pneumonia, is on the rise. The first part of the study introduces CAP as a
condition, shows the burden of the disease (statistically) worldwide and in SA as well. The
literature review explores epidemiology and aetiology of the disease. Focus was on
gathering data of the most prescribed antimicrobials. This report focuses on data collation
for the antimicrobials prescribed (which in turn shows trends or doctor prescribing
pattern), days spent in hospital, any possible correlation between choice of antimicrobial
and duration of admission. The secondary data collected was compared to several other
studies that had similar topics to have a point of reference for comparison with the findings
of this study under the results and discussion section. It was concluded first that
amoxicillin/clavulanate is effective for the treatment of pneumonia infection. Second that
ceftriaxone is an effective alternative for treating pneumonia compared to the classic
agents. Last the study concluded that the clinical outcomes for children hospitalized with
CAP on narrow-spectrum antibiotic are not significantly different from treatment with
broad-spectrum antibiotics
Description
A research report submitted in partial fulfilment of the requirements for the degree of Master of Science (Medicine) in Pharmaceutical Affairs to the Faculty of Health Sciences, School of Pharmacy, University of the Witwatersrand, Johannesburg, 2021